Hoppe Anne, Dani Pallavi, Mwangoka Grace, Vreden Stephen, Breton Guillaume, Ateudjieu Jerome, Nankabirwa Joaniter I, Sambo Júlia, Masaba Rose, Maparo Tatenda, Sibeko Goodman, Njouom Richard, Tchounga Boris, Ssewanyana Isaac, Chavula Chancy, Nchimunya Lindiwe, Djikeussi Tatiana, Accellam Sam, Cairo Hedley, Walcott David, Khan Aamir J, Khan Shaukat, Bausch Daniel G
FIND, Geneva, Switzerland.
Technical Strategy and Innovation, Elizabeth Glaser Pediatric AIDS Foundation, Geneva, Switzerland.
Am J Trop Med Hyg. 2024 Oct 8;112(4_Suppl):119-126. doi: 10.4269/ajtmh.23-0893. Print 2025 Apr 1.
During the COVID-19 pandemic, the need for making testing readily available was recognized as an important factor for individuals to help make informed decisions, including to isolate or seek care, and for policymakers to control transmission. Toward this end, FIND and the Access to COVID-19 Tools Accelerator funded 16 rapid operational research studies and one implementation project in Africa, the Caribbean, and Asia evaluating the utility, acceptability, and feasibility of different community-based SARS-CoV-2 testing approaches. Here, we discuss common factors and challenges encountered during study implementation. We note six key factors essential for success: 1) collaboration and partnerships; 2) buy-in of local stakeholders, including communities; 3) access to affordable supplies; 4) flexible financing; 5) effective approval systems; and 6) a skilled and motivated workforce. We also note various challenges that must be addressed to fully capitalize on these success factors. In particular, ethics committees are often not well equipped to assess operational research during outbreaks. Outbreaks, especially of novel pathogens, are unpredictable, and transmission dynamics are even more likely to change if the pathogen is prone to frequent mutations, such as SARS-CoV-2. Research that aims to evaluate strategies for curbing transmission must hence be easily and swiftly adaptable. This requires flexibility from researchers, funders, staff conducting the studies, and ethics and other approval committees. International guidelines for evaluating operational research protocols in outbreaks are needed to provide timely evidence to enable informed decisions by individuals, communities, and policymakers, thereby reducing both the human and the economic impact of outbreaks.
在新冠疫情期间,人们认识到让检测易于获得是帮助个人做出明智决策(包括隔离或寻求治疗)以及政策制定者控制传播的一个重要因素。为此,“被忽视疾病药物研发组织”(FIND)和“获取新冠工具加速器”在非洲、加勒比地区和亚洲资助了16项快速行动研究和1个实施项目,以评估不同社区层面的严重急性呼吸综合征冠状病毒2(SARS-CoV-2)检测方法的效用、可接受性和可行性。在此,我们讨论研究实施过程中遇到的共同因素和挑战。我们指出成功的六个关键因素:1)合作与伙伴关系;2)包括社区在内的当地利益相关者的支持;3)获得价格合理的物资;4)灵活的融资;5)有效的审批系统;6)一支技术熟练且积极性高的工作队伍。我们还指出,要充分利用这些成功因素,必须应对各种挑战。特别是,伦理委员会往往没有充分的能力在疫情期间评估行动研究。疫情,尤其是新型病原体引发的疫情,是不可预测的,如果病原体容易频繁变异,如SARS-CoV-2,传播动态更有可能发生变化。因此,旨在评估遏制传播策略的研究必须易于且迅速调整。这需要研究人员、资助者、开展研究的工作人员以及伦理和其他审批委员会具备灵活性。需要有评估疫情期间行动研究方案的国际准则,以便及时提供证据,使个人、社区和政策制定者能够做出明智决策,从而减少疫情对人类和经济的影响。